195 luciliae (3% от пациентите, лекувани с Enbrel, в сравнение с никой от получавалите плацебо пациенти).
193 placebo-treated patients) and by Crithidia luciliae assay (3% of patients treated with Enbrel compared to none of placebo-treated patients).